Biotech NewsREGENXBIO (RGNX) Reports $89M Revenue, $6.1M Profit in Q1 2025 BioTech Health XSeptember 5, 2025 REGENXBIO Inc. (NASDAQ:RGNX) is a pioneering biotechnology company based in Rockville, Maryland, focused on harnessing the power of… 0 Shares 0 0 0 0 0 0 0